Finance

Lists
Why is ELV up 3.44%?
Dive Deeper
ELV:NYSE
Elevance Health Inc
$ 414.75
+3.44%
(+13.81) 1D
10-р сарын 9, 12:02:36 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELV...
Open
$ 401.92
High
$ 418.56
Low
$ 400.94
Mkt. cap
86.95 тэрбум
Avg. vol.
1.14 сая
Volume
760.94 мян
52-wk high
$ 436.24
52-wk low
$ 274.84
Beta
0.70
Shares outstanding
216.87 сая
No. of employees
97 мян
Open
$ 401.92
High
$ 418.56
Low
$ 400.94
Mkt. cap
86.95 тэрбум
Avg. vol.
1.14 сая
Volume
760.94 мян
52-wk high
$ 436.24
52-wk low
$ 274.84
Beta
0.70
Shares outstanding
216.87 сая
No. of employees
97 мян
News stories
From web sources and news partners
Profile
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans. Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing /Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States. Wikipedia
About Elevance Health Inc
CEOGail Koziara Boudreaux
Employees96.6 мян
Founded1944
HeadquartersИндианаполис, Индиана, Америкийн Нэгдсэн Улс
SectorHealth care provider
Analyst ratings
Based on 17 analysts giving stock ratings to ELV in the past 3 months
Buy
Buy
10
Hold
7
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for ELV in the last 3 months.
Highest
Current $ 414.75
$ 488.00 (+17.66%)
Average
$ 446.40 (+7.63%)
Lowest
$ 393.00 (-5.24%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Mok CFA
Barclays
Buy
Maintained
$ 469.00
+13.1%
10/07/2026
Ben Hendrix
RBC Capital
Hold
Maintained
$ 424.00
+2.2%
10/07/2026
Lance Wilkes
Bernstein
Buy
Maintained
$ 488.00
+17.7%
10/05/2026
A.J. Rice
UBS
Buy
Maintained
$ 460.00
+10.9%
09/18/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
$ 473.00
+14%
09/15/2026
Kevin Fischbeck
Bank of America Securities
Buy
Maintained
$ 480.00
+15.7%
09/11/2026
David Toung
Argus Research
Hold
Maintained
-
-
08/20/2026
Whit Mayo
Leerink Partners
Hold
Reiterated
$ 395.00
-4.8%
07/17/2026
Ryan Langston
TD Cowen
Buy
Reiterated
$ 465.00
+12.1%
07/17/2026
David Windley
Jefferies
Buy
Maintained
$ 450.00
+8.5%
07/16/2026
Scott Fidel
Goldman Sachs
Hold
Maintained
$ 395.00
-4.8%
07/15/2026
Erin Wright
Morgan Stanley
Hold
Reiterated
$ 404.00
-2.6%
07/17/2026
Jason Cassorla
Guggenheim
Buy
Maintained
$ 455.00
+9.7%
07/15/2026
Michael Ha
Robert W. Baird
Hold
Maintained
$ 393.00
-5.2%
07/16/2026
Amit Daryanani
Evercore ISI
Hold
Maintained
-
-
07/15/2026
David S Macdonald
Truist Financial
Buy
Reiterated
$ 475.00
+14.5%
07/16/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$ 470.00
+13.3%
07/13/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$ 450.00
+8.5%
07/07/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
$ 476.00
+14.8%
06/08/2026
George Hill
Deutsche Bank
Buy
Upgraded
$ 498.00
+20.1%
05/20/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Upgraded
$ 360.00
-13.2%
05/19/2026
Next call 12 өдрийн дараа
10-р сарын 21. Лх, 14:30
Fiscal period
Q3 2026
EPS / Est. (USD)
- / $ 4.69
Revenue / Est. (USD)
- / 49.16 тэрбум
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
50.71 тэрбум
49.75 тэрбум
50.18 тэрбум
50.47 тэрбум
Cost of goods sold
38.14 тэрбум
38.06 тэрбум
35.62 тэрбум
37.02 тэрбум
Cost of revenue
38.14 тэрбум
38.06 тэрбум
35.62 тэрбум
37.02 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.65 тэрбум
10.75 тэрбум
11.79 тэрбум
11.04 тэрбум
Operating expense
10.81 тэрбум
10.92 тэрбум
11.90 тэрбум
11.15 тэрбум
Total operating expenses
48.95 тэрбум
48.98 тэрбум
47.52 тэрбум
48.17 тэрбум
Operating income
1.76 тэрбум
766.00 сая
2.66 тэрбум
2.30 тэрбум
Other non operating income
-
-
-
-
EBT including unusual items
1.41 тэрбум
215.00 сая
2.30 тэрбум
1.94 тэрбум
EBT excluding unusual items
1.41 тэрбум
399.00 сая
2.30 тэрбум
1.94 тэрбум
Income tax expense
219.00 сая
-331.00 сая
544.00 сая
483.00 сая
Effective tax rate
15.58%
-153.95%
23.61%
24.94%
Other operating expenses
-
-
-
-
Net income
1.19 тэрбум
547.00 сая
1.76 тэрбум
1.46 тэрбум
Net profit margin
2.34%
1.10%
3.52%
2.90%
Earnings per share
6.03
3.33
12.58
7.45
Interest and investment income
-
-
-
-
Interest expense
-351.00 сая
-367.00 сая
-357.00 сая
-364.00 сая
Net interest expenses
-351.00 сая
-367.00 сая
-357.00 сая
-364.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
2.14 тэрбум
1.17 тэрбум
3.02 тэрбум
2.67 тэрбум
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс